Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.

Fujimaki M, Fukumura Y, Saito T, Mitani K, Uchida S, Yokoyama J, Yao T, Ikeda K.

Hum Pathol. 2011 Dec;42(12):2052-5. doi: 10.1016/j.humpath.2011.02.021. Epub 2011 Jun 14.

PMID:
21676434
2.

Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.

Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H.

Mod Pathol. 2009 Dec;22(12):1575-81. doi: 10.1038/modpathol.2009.126. Epub 2009 Sep 11.

3.

Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.

García JJ, Hunt JL, Weinreb I, McHugh JB, Barnes EL, Cieply K, Dacic S, Seethala RR.

Hum Pathol. 2011 Dec;42(12):2001-9. doi: 10.1016/j.humpath.2011.02.028. Epub 2011 Jul 20.

PMID:
21777943
4.

t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.

O'Neill ID.

Oral Oncol. 2009 Jan;45(1):2-9. doi: 10.1016/j.oraloncology.2008.03.012. Epub 2008 May 16. Review.

PMID:
18486532
5.

CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.

Lennerz JK, Perry A, Dehner LP, Pfeifer JD, Lind AC.

Br J Dermatol. 2009 Oct;161(4):925-9. doi: 10.1111/j.1365-2133.2009.09200.x. Epub 2009 Apr 29.

PMID:
19438452
6.

CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.

Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK.

Genes Chromosomes Cancer. 2007 Jul;46(7):708-15.

PMID:
17437281
7.

A new type of MAML2 fusion in mucoepidermoid carcinoma.

Fehr A, Röser K, Heidorn K, Hallas C, Löning T, Bullerdiek J.

Genes Chromosomes Cancer. 2008 Mar;47(3):203-6.

PMID:
18050304
8.

MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.

Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y, Inagaki H.

Clin Cancer Res. 2006 Jul 1;12(13):3902-7.

9.

CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association.

Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK.

Genes Chromosomes Cancer. 2008 Apr;47(4):309-14. doi: 10.1002/gcc.20534.

PMID:
18181164
10.

A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.

Fehr A, Meyer A, Heidorn K, Röser K, Löning T, Bullerdiek J.

Genes Chromosomes Cancer. 2009 Sep;48(9):777-85. doi: 10.1002/gcc.20682.

PMID:
19521953
11.

Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.

Okumura Y, Miyabe S, Nakayama T, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H.

Histopathology. 2011 Jul;59(1):90-7. doi: 10.1111/j.1365-2559.2011.03890.x. Epub 2011 Jun 13.

PMID:
21668476
12.

Oncocytic mucoepidermoid carcinoma of parotid gland origin.

Brannon RB, Willard CC.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Dec;96(6):727-33. Review.

PMID:
14676764
13.

Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.

Noda H, Okumura Y, Nakayama T, Miyabe S, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H.

Cancer Sci. 2013 Jan;104(1):85-92. doi: 10.1111/cas.12039. Epub 2012 Nov 8.

14.

CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.

Von Holstein SL, Fehr A, Heegaard S, Therkildsen MH, Stenman G.

Oncol Rep. 2012 May;27(5):1413-6. doi: 10.3892/or.2012.1676. Epub 2012 Feb 6.

PMID:
22323114
15.

New insights into the nature of Warthin's tumour.

O'Neill ID.

J Oral Pathol Med. 2009 Jan;38(1):145-9. doi: 10.1111/j.1600-0714.2008.00676.x. Epub 2008 Jul 21. Review.

PMID:
18647217
16.

t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.

Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ.

Nat Genet. 2003 Feb;33(2):208-13. Epub 2003 Jan 21. Erratum in: Nat Genet. 2003 Mar;33(3):430.

PMID:
12539049
17.

Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.

Lennerz JK, Perry A, Mills JC, Huettner PC, Pfeifer JD.

Am J Surg Pathol. 2009 Jun;33(6):835-43. doi: 10.1097/PAS.0b013e318190cf5b.

PMID:
19092631
18.

Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.

Chen Z, Chen J, Gu Y, Hu C, Li JL, Lin S, Shen H, Cao C, Gao R, Li J, Ha PK, Kaye FJ, Griffin JD, Wu L.

Oncogene. 2014 Jul 17;33(29):3869-77. doi: 10.1038/onc.2013.348. Epub 2013 Aug 26.

PMID:
23975434
19.

Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence In Situ Hybridization and Whole-slide Imaging.

Ishibashi K, Ito Y, Masaki A, Fujii K, Beppu S, Sakakibara T, Takino H, Takase H, Ijichi K, Shimozato K, Inagaki H.

Am J Surg Pathol. 2015 Nov;39(11):1479-87. doi: 10.1097/PAS.0000000000000507.

PMID:
26457352
20.

CRTC1/MAML2 fusion transcript in central mucoepidermoid carcinoma of mandible--diagnostic and histogenetic implications.

Bell D, Holsinger CF, El-Naggar AK.

Ann Diagn Pathol. 2010 Dec;14(6):396-401. doi: 10.1016/j.anndiagpath.2010.05.009.

PMID:
21074686
Items per page

Supplemental Content

Write to the Help Desk